Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Henlez logo — Early-stage, Danish biotech company in the dermatology space

Henlez

Early-stage, Danish biotech company in the dermatology space

Founded 2019 Denmark Denmark 5 employees Seed Total: $1.00M Biopharma, Biotechnology

General Information

Company Name Henlez
Founded Year 2019
Location Denmark Denmark +1
Employees 5
Industries Biopharma, Biotechnology
Funding Stage Seed
Social

Get notified when Henlez moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Henlez

Henlez is a Danish early-stage biotech company in the dermatology space, aiming to make significant advancements in the field of dermatological treatment. Founded in 2019, the company has received a notable €1.00M Seed Round investment on 24 October 2022 from Eir Ventures and Karolinska. The company's focus on biopharma and biotechnology aligns with the current trends in the healthcare industry, making it an attractive prospect for investors. With its headquarters in Denmark, Henlez is strategically positioned within the European biotech landscape. The company's innovative approach and recent funding indicate a promising trajectory, positioning it as a noteworthy player in the biotech startup scene. For venture capital firms seeking opportunities in biotech and pharmaceutical sectors, Henlez represents a compelling investment prospect with the potential for substantial growth and impact in the dermatology space.

Taxonomy: biotech, dermatology, enzyme therapy, skin treatment, early-stage company, Danish company, topical treatments, follicular skin problems, precise enzymes, disruptive technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor
•••• •••• 		24 Oct 2022

Henlez Alternatives & Competitors

Henlez vs
Complete Family Dermatology
Complete Family Dermatology United States

The health of your skin is important, and it deserves the attention of a specialist.

6 employees
Health Care
Henlez vs
BENEV Company Inc
BENEV Company Inc United States

Progressive Skin Science

98 employees
Manufacturing, Pharmaceutical
Henlez vs
The Natural Nipple
The Natural Nipple United States

Pioneering Advancements to Empower Breastfeeding, Promote Bonding, & Optimize Wellness Worldwide!

Grant
11 employees
Health and Wellness, Women's Health

FAQ About Henlez

Early-stage, Danish biotech company in the dermatology space
Henlez was founded in 2019.
Henlez is headquartered in Denmark.
Henlez operates in the following industries: Biopharma, Biotechnology.
Henlez has approximately 5 employees.
Henlez has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
Top alternatives and competitors to Henlez include Complete Family Dermatology, BENEV Company Inc, The Natural Nipple, Ultra, Inc., Marnel Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Henlez and Complete Family Dermatology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Henlez and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy